American Century Companies Inc. Has $1.54 Million Stock Position in CorVel Co. (NASDAQ:CRVL)

American Century Companies Inc. lifted its position in shares of CorVel Co. (NASDAQ:CRVL) by 200.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,832 shares of the business services provider’s stock after purchasing an additional 9,233 shares during the quarter. American Century Companies Inc.’s holdings in CorVel were worth $1,539,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. FMR LLC boosted its position in CorVel by 193.1% in the third quarter. FMR LLC now owns 4,306 shares of the business services provider’s stock valued at $1,408,000 after buying an additional 2,837 shares in the last quarter. Captrust Financial Advisors bought a new position in shares of CorVel in the third quarter valued at approximately $217,000. Verition Fund Management LLC acquired a new position in shares of CorVel in the 3rd quarter worth approximately $213,000. State Street Corp grew its position in CorVel by 0.8% during the 3rd quarter. State Street Corp now owns 360,068 shares of the business services provider’s stock worth $117,703,000 after acquiring an additional 2,959 shares during the last quarter. Finally, Wolverine Trading LLC increased its holdings in CorVel by 224.1% during the 3rd quarter. Wolverine Trading LLC now owns 1,241 shares of the business services provider’s stock valued at $398,000 after purchasing an additional 2,241 shares in the last quarter. 51.36% of the stock is currently owned by institutional investors.

Insider Transactions at CorVel

In other news, Director Steven J. Hamerslag sold 10,000 shares of the stock in a transaction on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the transaction, the director now directly owns 314,000 shares in the company, valued at approximately $38,772,720. This represents a 3.09 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Brandon O’brien sold 1,523 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the sale, the chief financial officer now directly owns 17,142 shares in the company, valued at $2,049,497.52. The trade was a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 32,200 shares of company stock worth $3,824,115 over the last quarter. Company insiders own 47.57% of the company’s stock.

CorVel Trading Up 7.3 %

Shares of CorVel stock opened at $115.56 on Thursday. CorVel Co. has a 12 month low of $76.20 and a 12 month high of $128.61. The company has a market capitalization of $5.94 billion, a PE ratio of 67.98 and a beta of 0.94. The stock’s fifty day simple moving average is $111.80 and its 200 day simple moving average is $114.92.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of CorVel from a “hold” rating to a “buy” rating in a research report on Tuesday.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.